James Pena, Director, Product Management – Digital Science & Automation Solutions, Thermo Fisher Scientific, will be speaking at the DDW track Creating Cures: The role of lab automation in successful drug discovery at SLAS2026.

He will present: From Data to Decisions: Digital-Ready Laboratories Powered by Automation.

You can register your interest here.

For the third year running DDW is organising this series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA).

This programme, Creating Cures: The role of lab automation in successful drug discovery at SLAS2026 – will highlight innovative research using technology in drug development and will be held in the Ignite Theater on 9 and 10 February

James Pena is Director of Product Management for the Digital Science and Automation Solutions division at Thermo Fisher Scientific. His role focuses on driving its product portfolio, specifically enterprise lab solutions and cloud-hosted laboratory information management systems (LIMS), to orchestrate diverse scientific workflows and harmonise data for deep, AI-enabled analytics. Having started his career as a microbiologist in the lab, James has since transitioned to projects that support scientists in their digital transformation journey.

The track is sponsored by Collaborative Drug Discovery (CDD), Brooks Automation and Thermo Fisher Scientific.

Let us know if you’re attending by registering your interest.